Athersys (ATHX) Appoints Neema Mayhugh to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. JBLU
4. ANT
5. META
6. SSD
7. AGYS
8. PECO
9. AMKR
10. BX

Go back to Athersys (ATHX) Appoints Neema Mayhugh to its Board

Athersys Appoints Neema Mayhugh, PhD to its Board of Directors

August 11, 2023 8:00 AM EDT

Healthcare Executive and Strategy Consultant Brings Considerable Innovation, Commercialization and Entrepreneurial Expertise

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today the appointment of Neema Mayhugh, PhD to its Board of Directors. Dr. Mayhugh is an executive with more than 20 years of experience in healthcare consulting, industry, academic and hospital settings.

Dr. Mayhugh currently serves as the Founder and Managing Partner of Wave Strategy, a consultancy focused on the rapid commercialization of healthcare innovations. Under her leadership, Wave... More